跳至主要内容
临床试验/NCT00208936
NCT00208936终止2 期

Phase II Study of Pre-Operative Chemotherapy With Taxol, Cisplatin, and 5-Fluorouracil Followed by G-CSF in Patients With Resectable Local-Regional Carcinoma of Esophagus

Emory University2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 1996年1月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
20
试验地点
2

研究概览

简要总结

This study is designed pre-operative for patients with resectable, local-regional carcinoma of the esophagus.

详细描述

This study is designed for patients with resectable, local-regional carcinoma of the esophagus. In a pre-operative setting, chemotherapy with Taxol, Cisplatin, and 5-Fluorouracil will be administered followed by G-CSF.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Measurable disease with resectable local-regional carcinoma of the esophagus. 18 years of age or older.

排除标准

  • Pregnant or lactating. Non-resectable local-regional carcinoma of the esophagus.

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nabil F. Saba

Associate Professor

Emory University

研究点 (2)

Loading locations...

相似试验